Your browser doesn't support javascript.
loading
Disease-free survival as a predictor of overall survival in localized renal cell carcinoma following initial nephrectomy: A retrospective analysis of Surveillance, Epidemiology and End Results-Medicare datac.
Haas, Naomi B; Song, Yan; Willemann Rogerio, Jaqueline; Zhang, Su; Carley, Christopher; Zhu, JingJing; Bhattacharya, Rituparna; Signorovitch, James; Sundaram, Murali.
Afiliación
  • Haas NB; University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.
  • Song Y; Analysis Group, Inc., Boston, Massachusetts, USA.
  • Willemann Rogerio J; Merck & Co., Inc., Rahway, New Jersey, USA.
  • Zhang S; Analysis Group, Inc., Boston, Massachusetts, USA.
  • Carley C; Analysis Group, Inc., Boston, Massachusetts, USA.
  • Zhu J; Analysis Group, Inc., Boston, Massachusetts, USA.
  • Bhattacharya R; Merck & Co., Inc., Rahway, New Jersey, USA.
  • Signorovitch J; Analysis Group, Inc., Boston, Massachusetts, USA.
  • Sundaram M; Merck & Co., Inc., Rahway, New Jersey, USA.
Int J Urol ; 30(3): 272-279, 2023 03.
Article en En | MEDLINE | ID: mdl-36788716
ABSTRACT

OBJECTIVES:

This study aimed to assess whether disease-free survival (DFS) may serve as a predictor for long-term survival among patients with intermediate-high risk or high risk renal cell carcinoma (RCC) post-nephrectomy when overall survival (OS) is unavailable.

METHODS:

The Surveillance, Epidemiology and End Results-Medicare database (2007-2016) was used to identify patients with non-metastatic intermediate-high risk and high risk RCC post-nephrectomy. Landmark analysis and Kendall's τ were used to evaluate the correlation between DFS and OS. Multivariable regression models were used to quantify the incremental OS post-nephrectomy associated with increased time to recurrence among patients with recurrence, adjusting for baseline covariates.

RESULTS:

A total of 643 patients were analyzed; mean age of 75 years; >95% of patients had intermediate-high risk RCC at diagnosis; 269 patients had recurrence post-nephrectomy. For patients with versus without recurrence at the landmark points of 1, 3, and 5 years post-nephrectomy, the 5-year OS were 37.0% versus 70.1%, 42.3% versus 72.8%, and 53.2% versus 78.6%, respectively. The Kendall's τ between DFS and OS post-nephrectomy was 0.70 (95% CI 0.65, 0.74; p < 0.001). After adjusting for baseline covariates, patients with one additional year of time to recurrence were associated with 0.73 years longer OS post-nephrectomy (95% CI 0.40, 1.05; p < 0.001).

CONCLUSION:

The significant positive association of DFS and OS among patients with intermediate-high risk and high risk RCC post-nephrectomy from this study supports the use of DFS as a potential predictor of OS for these patients when OS data are immature.
Asunto(s)
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Carcinoma de Células Renales / Neoplasias Renales Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Límite: Aged / Humans País/Región como asunto: America do norte Idioma: En Revista: Int J Urol Asunto de la revista: UROLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Carcinoma de Células Renales / Neoplasias Renales Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Límite: Aged / Humans País/Región como asunto: America do norte Idioma: En Revista: Int J Urol Asunto de la revista: UROLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos